Published in J Neurol Sci on January 01, 1997
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics (2006) 1.50
Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study. J Inherit Metab Dis (2008) 1.39
Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ (1997) 3.23
Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol (2008) 2.77
Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery (1994) 2.74
Characterization of 2-mum DNA of Saccharomyces cerevisiae by restriction fragment analysis and integration in an Escherichia coli plasmid. Proc Natl Acad Sci U S A (1976) 2.47
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol (1994) 2.38
Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (1999) 2.12
Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem (1971) 2.11
Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet (1999) 2.04
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut (2009) 1.97
A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res (1976) 1.91
The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase. Proc Natl Acad Sci U S A (1973) 1.86
Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer (1994) 1.85
Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging (1997) 1.79
Desmin myopathy. Brain (2004) 1.79
The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med (1993) 1.71
First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol (2009) 1.65
Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol (1990) 1.62
[Prevention without radiation--a strategy for comprehensive early detection using magnetic resonance tomography]. Radiologe (2002) 1.55
Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med (1996) 1.52
Cardiac puncture of fetus with Hurler's disease avoiding abortion of unaffected co-twin. Lancet (1978) 1.52
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell (1997) 1.47
Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol (1996) 1.46
I-cell disease: deficiency of extracellular hydrolase phosphorylation. Biochem Biophys Res Commun (1979) 1.46
Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol (1998) 1.46
A -glucuronidase deficiency mucopolysaccharidosis: studies in cultured fibroblasts. Arch Biochem Biophys (1973) 1.45
Pathogenesis of cervical artery dissections: association with connective tissue abnormalities. Neurology (2001) 1.45
Endovascularly or surgically treated vertebral artery and posterior inferior cerebellar artery aneurysms: clinical analysis and results. Zentralbl Neurochir (2005) 1.45
Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol (1999) 1.45
Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci U S A (1996) 1.44
Ultrastructural connective tissue abnormalities in patients with spontaneous cervicocerebral artery dissections. Ann Neurol (1998) 1.42
A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening. Am J Hum Genet (1992) 1.41
Hypoglycemic effect of the water extract of Smallantus sonchifolius (yacon) leaves in normal and diabetic rats. J Ethnopharmacol (2001) 1.41
Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study. J Inherit Metab Dis (2008) 1.39
Recurrent neurovascular hypertension: MR findings before and after surgical treatments. AJNR Am J Neuroradiol (2001) 1.39
Pallidal stimulation: an alternative to pallidotomy? J Neurosurg (1997) 1.39
[Building the future together]. Nuklearmedizin (2012) 1.39
Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K. Neuropediatrics (2003) 1.39
Prospective evaluation of the prognostic significance of evoked potentials in acute basilar occlusion. Crit Care Med (1993) 1.38
Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns. Clin Neuroradiol (2014) 1.38
A transgenic rat model of Charcot-Marie-Tooth disease. Neuron (1996) 1.37
Aneurysmal rupture during embolization with Guglielmi detachable coils: causes, management, and outcome. AJNR Am J Neuroradiol (2001) 1.36
Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet (1983) 1.36
Expression and processing of bacterial beta-lactamase in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1981) 1.35
Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet (1973) 1.35
Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet (2001) 1.34
Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol (1996) 1.34
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. J Inherit Metab Dis (2005) 1.33
Ultrastructure of human and experimental ependymomas. A comparative study. J Neuropathol Exp Neurol (1972) 1.31
Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem (1992) 1.28
Hearing loss in facioscapulohumeral dystrophy. Eur J Pediatr (1986) 1.28
Neuromyopathy and vitamin E deficiency in man. Neuropediatrics (1981) 1.26
The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine. J Neurol Neurosurg Psychiatry (1984) 1.26
Mucopolysaccharidosis. VII. Beta-glucuronidase deficiency. Humangenetik (1974) 1.26
Does arterial recanalization improve outcome in carotid territory stroke? Stroke (1995) 1.24
Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Hum Mutat (1998) 1.23
Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord (2000) 1.22
Very low arylsulfatase A and cerebroside sulfatase activities in leukocytes of healthy members of metachromatic leukodystrophy family. Am J Hum Genet (1977) 1.21
Facilitation and inhibition of the human H reflex as a function of the amplitude of the control reflex. Electroencephalogr Clin Neurophysiol (1980) 1.21
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr (1989) 1.20
Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain (2002) 1.20
Diagnosis of Tay-Sachs disease by hexosaminidase activity in leukocytes and amniotic fluid cells. Isr J Med Sci (1971) 1.20
Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology (2001) 1.19
Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency. Ann Neurol (1984) 1.19
Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts. Biochem Biophys Res Commun (1977) 1.18
Consequences of mutations within the C terminus of the FHL1 gene. Neurology (2009) 1.18
Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase. Biochem Biophys Res Commun (1974) 1.17
Neurological outcome in adult patients with early-treated phenylketonuria. Eur J Pediatr (1998) 1.17
Hexosaminidase A deficiency in adults. Am J Med Genet (1986) 1.16
Heterogeneity of erythrocyte catalase. Correlations between sulfhydryl group content, chromatographic and electrophoretic properties. Eur J Biochem (1969) 1.15
Comparison of eyeblink conditioning in patients with superior and posterior inferior cerebellar lesions. Brain (2003) 1.14
Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem (2001) 1.14
Diagnostic and therapeutic consequences of repeat brain imaging and follow-up vascular imaging in stroke patients. AJNR Am J Neuroradiol (1999) 1.13
Early lesion of Pelizaeus-Merzbacher disease: electron microscopic and biochemical study. J Neuropathol Exp Neurol (1973) 1.13
Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (1987) 1.13
Biochemical heterogeneity of the Sanfilippo syndrome: preliminary characterization of two deficient factors. Biochem Biophys Res Commun (1971) 1.12
Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci (1991) 1.12
Leukodystrophy incidence in Germany. Am J Med Genet (1997) 1.12
Myopathy associated with Marfan's syndrome. Fine structural and histochemical observations. Neurology (1973) 1.12
Phosphate metabolites in lymphoid, Friend erythroleukemia, and HeLa cells observed by high-resolution 31P nuclear magnetic resonance. Proc Natl Acad Sci U S A (1978) 1.11
The Hunter corrective factor. Purification and preliminary characterization. J Biol Chem (1972) 1.11
Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector. Gene Ther (2000) 1.11
Carotid cavernous fistula due to a ruptured intracavernous aneurysm of the internal carotid artery: treatment with selective endovascular occlusion of the aneurysm. J Neurol Neurosurg Psychiatry (2001) 1.11
Tumor-like amyloid formation (amyloidoma) in the brain. J Neurol (1981) 1.10
Endovascular therapy of arteriovenous fistulae with electrolytically detachable coils. Neuroradiology (1999) 1.10
Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem (1991) 1.10
Eccrine sweat glands are not innervated in hereditary sensory neuropathy type IV. An electron-microscopic study. Acta Neuropathol (1981) 1.10
Ganglioside catabolism in hexosaminidase A-deficient adults. Nature (1974) 1.10
The human hippocampus at 7 T--in vivo MRI. Hippocampus (2009) 1.10
Inclusion body myositis presenting with isolated erector spinae paresis. Neurology (1995) 1.10
Alcohol-related acute axonal polyneuropathy: a differential diagnosis of Guillain-Barré syndrome. Arch Neurol (1998) 1.10
Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. Neuropediatrics (2002) 1.09
Perspectives on screening and prevention of Tay-Sachs disease in Israel. Prog Clin Biol Res (1977) 1.08
A mutation in myotilin causes spheroid body myopathy. Neurology (2005) 1.07
Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype. Neurology (1981) 1.07
Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy. Neurology (2003) 1.07